2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
ContributorsMach, François; Baigent, Colin; Catapano, Alberico L; Koskinas, Konstantinos C; Casula, Manuela; Badimon, Lina; Chapman, M John; De Backer, Guy G; Delgado, Victoria; Ference, Brian A; Graham, Ian M; Halliday, Alison; Landmesser, Ulf; Mihaylova, Borislava; Pedersen, Terje R; Riccardi, Gabriele; Richter, Dimitrios J; Sabatine, Marc S; Taskinen, Marja-Riitta; Tokgozoglu, Lale; Wiklund, Olov; ESC Scientific Document Group
Published inEuropean heart journal, vol. 41, no. 1, p. 111-188
Errata
- List of post-publication corrections that have been made to these Guidelines.
- DOI : 10.1093/eurheartj/ehz826
- PMID : 31837134
Publication date2020-01-01
First online date2019-08-31
Abstract
Keywords
- Guidelines
- Apolipoprotein B
- Cholesterol
- Dyslipidaemias
- Familial hypercholesterolaemia
- High-density lipoproteins
- Lipoprotein remnants
- Lipoprotein(a)
- Low-density lipoproteins
- Total cardiovascular risk
- Treatment (adherence)
- Treatment (drugs)
- Treatment (lifestyle)
- Triglycerides
- Very low-density lipoproteins
- Cardiovascular Diseases / prevention & control
- Dyslipidemias / therapy
- Heart Disease Risk Factors
- Humans
- Lipids
- Risk Factors
- Triglycerides
Affiliation
Citation (ISO format)
MACH, François et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification</i> to reduce <i>cardiovascular risk</i>. In: European heart journal, 2020, vol. 41, n° 1, p. 111–188. doi: 10.1093/eurheartj/ehz455
Main files (1)
Article (Published version) - after corrections
Secondary files (1)
Updates (1)
Corrigendum
Identifiers
- PID : unige:165849
- DOI : 10.1093/eurheartj/ehz455
- PMID : 31504418
ISSN of the journal0195-668X
